Overall survival of children and adolescents with mature B cell non ‐Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - July 9, 2018 Category: Hematology Authors: Mitchell Cairo , Anne Auperin , Sherrie L. Perkins , Ross Pinkerton , Lauren Harrison , Stanton Goldman , Catherine Patte Source Type: research